Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01477840
What this trial is testing

Comparative of Effects of Sublingual Misoprostol and Infusion Oxytocin in Reduction of Bleeding at Cesarean

Who this might be right for
Bleeding Intraoperative
Soudabeh Eshghi ali 180
Testing effectiveness (Phase 2)Study completedNCT00300950
What this trial is testing

Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer

Who this might be right for
Pancreas Cancer
GlobeImmune 176
Testing effectiveness (Phase 2)Study completedNCT03558191
What this trial is testing

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Who this might be right for
Nasopharyngeal Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 156
Not applicableUnknownNCT02735291
What this trial is testing

Study Evaluating the Efficacy and Safety With CAR-T for Recurrent or Refractory Acute Non T Lymphocyte Leukemia

Who this might be right for
Leukemia
Sinobioway Cell Therapy Co., Ltd. 72
Testing effectiveness (Phase 2)Ended earlyNCT00544674
What this trial is testing

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Proacta, Incorporated 5
Testing effectiveness (Phase 2)Active Not RecruitingNCT06254274
What this trial is testing

RAY1225 in Participants With Type 2 Diabetes

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Guangdong Raynovent Biotech Co., Ltd 210
Large-scale testing (Phase 3)Study completedNCT00157118
What this trial is testing

Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C Deficiency

Who this might be right for
Protein C Deficiency
Baxalta now part of Shire 18
Testing effectiveness (Phase 2)Ended earlyNCT00299390
What this trial is testing

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bayer 10
Not applicableWithdrawnNCT01811810
What this trial is testing

Proton Therapy for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Ended earlyNCT04352413
What this trial is testing

PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy

Who this might be right for
Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 45
Testing effectiveness (Phase 2)Study completedNCT03449082
What this trial is testing

Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)

Who this might be right for
Lateral Epicondylitis
Seoul National University Hospital 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03842982
What this trial is testing

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)

Who this might be right for
Ovary NeoplasmsOvarian CancerOvarian Carcinoma
Centre Oscar Lambret 362
Testing effectiveness (Phase 2)Study completedNCT00058123
What this trial is testing

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 55
Testing effectiveness (Phase 2)Looking for participantsNCT04992780
What this trial is testing

Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer Stage
University of Kansas Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT03500159
What this trial is testing

Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Who this might be right for
Chronic ProstatitisChronic Pelvic Pain Syndrome
Aquinox Pharmaceuticals (Canada) Inc. 3
Not applicableEnded earlyNCT01914679
What this trial is testing

A Prospective Evaluation of RINCE to Reduce Fibromyalgia Effects - University of Michigan

Who this might be right for
Fibromyalgia
University of Michigan 17
Testing effectiveness (Phase 2)WithdrawnNCT01733836
What this trial is testing

Prostate Cancer Active Surveillance Metformin Trial

Who this might be right for
Prostate Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)Ended earlyNCT01984892
What this trial is testing

Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)

Who this might be right for
MelanomaSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma of the Skin+3 more
Nina Bhardwaj 8
Testing effectiveness (Phase 2)Study completedNCT00764634
What this trial is testing

Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B

Who this might be right for
Botulism Vaccine
DynPort Vaccine Company LLC, A GDIT Company 440
Testing effectiveness (Phase 2)Looking for participantsNCT07110064
What this trial is testing

QL1706+Lenvatinib+AG Regimen as First-line Treatment for Advanced Metastatic Pancreatic Cancer

Who this might be right for
Advance Pancreatic Cancer
Du Juan 80
Next Page